Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company [Yahoo! Finance]
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025 [Yahoo! Finance]
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering